Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.
Related Posts
Palo Alto Networks beats on earnings and revenue, misses on gross margin
Palo Alto Networks reported better-than-expected earnings and revenue for the latest quarter but missed on gross margin.
Trump picks former Development Finance Corp. CEO Adam Boehler as special envoy for hostage affairs
Adam Boehler was on the team that negotiated the Abraham Accords, a significant foreign policy achievement of Donald Trump’s first term.
Alphabet reported a revenue miss that sent the stock tumbling. What analysts are saying
Here are what Wall Street analysts are saying after Alphabet’s fourth-quarter earnings announcement.